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The  accompanying  paper  (1)  presented  data  concerning  the  position  or 
resting place of antigen-antibody complexes in small vessel wails immediately 
after they leave the circul~tion under an anaphylactic provocation. The pos- 
sible significance of this resting place in certain diseases of blood vessels was 
noted.  The  studies  presented  here  were  undertaken  to  investigate  several 
different methods of injuring vessel walls  that may provoke the localization 
of circulating complexes, and to study the pharmacologic background of each 
of these at least in part. These different methods of causing injury to the vessel 
included  damage  following the  interaction  of  antigen  and  antibody  in  the 
vicinity of the vessels (systemic anaphylaxis), exposure to preformed anaphy- 
latoxin,  and  direct attack  by antibody directed against  constituents  of the 
vessel wall itself. It was hoped that studies such as these might help in the 
overall understanding of the mechanisms of localization of circulating macro- 
molecules that,  after their deposition, may bring  about vascular  damage. 
Materials and Methods 
Animals, antigens, and antibodies, with the exceptions  noted below,  were the same as those 
described in the adjoining article (1). 
Antibodies against Forssman Antigen.--Anti-Forssman sera were obtained from rabbits 
following multiple injections of boiled sheep red blood  cell stromata (2). Sera with antibody 
concentrations greater than 1:1024 were pooled. 
Antibodies against Guinea Pig Platdets.--Guinea pig phtelets were prepared from pooled 
plasma of heparinized guinea pigs (3). The antisera produced were repeatedly absorbed with 
pooled guinea pig leukocytes, red ceUs, and plasma. 
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Pharmacologic Agents.--Histamine  acid phosphate was obtained from Eli Lilly & Company, 
Indianapolis,  5-hydroxytryptamine  (5-HT  or  serotonin)  from  Nutritional  Biochemicals 
Corp., Cleveland; lysergic acid diethylamide  (LSD) from Sandoz Pharmaceuticals,  Hanover, 
New Jersey, chlorphenamine (chlortrimeton)  from  Schering Corp., Bloomfield, New Jersey; 
pyrilamine  (neoantergan)  and  carbachol (carcholin) from Merck Sharp  & Dohme Research 
Laboratories,  West Point, Pennsylvania; octylamine  (armeen 8D)  from Armour  Industrial 
Chemical Co., Chicago; and compound 48/80 from Burroughs  Wellcome & Company, Inc., 
Tuckahoe, New York. 
Anaphylatoxin.--The generic name anaphylatoxin  is used here to represent the vasoactive 
material or materials released from fresh serum upon addition of antigen-antibody precipitates 
or other substances.  Anaphylatoxin  and heated  control serum were prepared  from fresh rat 
serum by the method given by Osier, eta/. (4). Briefly, fresh rat serum was mixed with pre- 
formed, washed precipitates  of Ea-anti-Ea (formed at the point of equivalence) in the ratio 
of 30 mg (Ab N) per ml of rat serum. The two were thoroughly mixed and incubated  at 
37°C for 90 minutes.  After cooling to 0°C for 1 hour,  the precipitate  was centrifuged  away 
at  12,000 g for 30 minutes  at 0-4°C. The superuatant  was used without dilution.  Control 
serum was prepared  simultaneously  in exactly  the same manner  using the same rat serum, 
except the rat serum was heated to 56°C for 30 minutes prior to incubation with the immune 
precipitate. 
Detection of Mast Cells in Tissues.--In order to demonstrate  the presence of mast cells, it 
was found necessary to fix guinea pig tissues in 50 per cent ethanol containing 4 per cent lead 
subacetate  according to the method of Mota (5). 
Fluorescent Antibody Technique.--The fluorescent  technique  of Coons and  Kaplan  (6) 
was used and control tests as mentioned in the adjoining article were employed. 
RESULTS 
Several  methods  of bringing  about  the  localization  of circulating  antigen- 
antibody were studied.  As was noted in Table II of the accompanying paper, 
when  guinea  pigs with  circulating  complexes were  subjected  to  anaphylactic 
shock using an unrelated  antigen-antibody  system,  the  circulating  complexes 
became deposited in the walls of venules in many organs of the body. In addi- 
tion  to  this  method  (classical  passive  systematic  anaphylaxis)  of  provoking 
localization  of the  circulating complexes,  several  other methods  of producing 
shock were tested. 
1.  Localization  Follmving  Shock  by Large  Doses  of Soluble  Complexes.--In. 
jections of large doses of soluble complexes were also found to lead to the de- 
position  of  the  same  circulating  antigen-antibody  complexes.  Twenty-five 
guinea  pigs were  injected  intravenously  with  varying  amounts  of BSA-anti- 
BSA complexes, varying from 1.85 to 7.0 mg Ab N. Of these, 7 animals died of 
fatal anaphylaxis,  2 showed moderate anaphylactic symptoms, 3 mild, and the 
rest  none.  These results  were similar  to those reported  by Germuth  and Mc- 
Kinnon (7) and by us (8). Fluorescence revealed a  marked vascular deposition 
of complexes in the fatal group, relatively less in the guinea pigs showing more 
mild  anaphylactic symptoms, and none in animals without symptoms. Hence, 
it appeared  that anaphylactic signs were a  necessary concomitant to localiza- 
tion of circulating complexes and that when such signs were elicited, complexes 
would deposit in amounts roughly corresponding to the degree of anaphylaxis. CHARLES  G.  COCHRANE  505 
2. Localization Subsequent to Shock Caused by Injections of Large Quantities 
of Sensitizing Antibody Followed by Challenge with Antigen.--It was also possible 
to provoke localization of antigen and rabbit globulin by sensitizing guinea pigs 
with large quantities of anti-BSA and after 18 hours,  challenging with BSA 
as noted in Table I. Those animals receiving 1.50 mg Ab N  or greater as a 
sensitizing dose showed localization in venules following antigenic challenge. 
Pharmacodynamic  considerations: With the observation of the deposition in 
vessels  of  circulating  macromolecules during  the  state  of  antigen-antibody 
anaphylaxis in the guinea pigs, it was deemed important to analyze, super- 
ficially at least, the pharmacologic cause or causes of the deposition. I-Iista- 
TABLE I 
Localization of Antigen and Rabbit Globulin in  Vessds of Sensitized Guinea Pigs Following 
Antigenic Challenge* 
Sensitized  Challenging  Anaphylactic  Localization of BSA and RGG  No. of guinea pigs  anti-BSA Ab N  BSA (N)  sxgns 
~g 
2.50 
1.50 
0.50 
0.10 
0.03 
mg 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
Death 
Death 
Death 
Death 
Death 
Neg. 
Moderate to marked 
Trace 
Neg. 
Neg. 
Neg. 
Neg. 
* All animals challenged intravenously 18 hours following  intravenous sensitization  with 
antibody. 
mine,  5-hydroxytryptamine (5-HT)  and choline derivatives were  evaluated. 
To accomplish this, use was made of specific inhibitors of the two vasoactive 
amines,  histamine and  5-HT.  Two  antihistaminics,  chlorphenamine  (chlor- 
trimeton), and pyrilamine (neoantergan) were employed, As may be seen in 
Table II, it was found that anaphylaxis was inhibited by pretreatment with 
antihistaminics, as would be anticipated, and in addition, there was little or no 
observable deposition of the circulating complexes in vessel walls. The 5-HT 
inhibitor lyserglc acid diethylamide (LSD) was employed in dosages up to 3 
times that capable of completely blocking the lethal effects of 20 mg of 5-HT. 
This is many times the total quantity of 5-HT within the entire guinea pig. As 
shown in Table II, the large dosages of LSD were found incapable of blocking 
the anaphylactic localization of circulating complexes even when, using small 
dosages of antibody, mild anaphylactic stimulation was given. Attempts were 
also made to cause the localization of circulating complexes with intravenous 
injections of 5-HT, employing the same preparation and amount of complexes 
shown in Table II, and using up to 20 mg (superlethal dosage) of 5-HT. It was 
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localization in a  small percentage of animals. In contrast, injections of 100 #g 
of histamine (base) brought about widespread localization in small vessels. This 
localization  by  extrinsic  histamine  resembled  in  all  respects  that  following 
anaphylactic shock.  In further experiments,  the choline derivative carbachol 
was used to see if it was capable of causing deposition of circulating complexes. 
By injecting  200  #g  carbachol  intracutaneously,  the  guinea  pigs  underwent 
symptoms typical of systemic anaphylaxis, and had pulmonary changes in the 
gross and microscopically identical  with  that  seen in  anaphylaxis.  However, 
TABLE  IX 
Effects of Histamine and 5-Hydroxytryplamine (5-HT) Antagonists on the Anaphylactic 
Localim.tion of Circulating Antigen-Antibody Complexes* 
Antihistaminic 
No. of 
guinea  pigs  Chlorphen- 
amine 
intra- 
venously:~ 
mg 
5  2.0 
7 
5 
7 
4 
6 
10 
1~'lamine 
(mtramus- 
cularly)§ 
mg 
1.0 
m 
5-HT  LSD 
(intra- 
muscularly) 
mg 
0.25¶ 
--¶ 
0.25 
Soluble 
complexes 
(Ab Nintra- 
venously) 
mg 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
Anaphylactic  signs 
Neg. 
Neg. 
Death 
Mild-rood. 
Mild-rood. 
Death 
Death 
Vascular localization 
Neg. or trace 
Neg. or trace 
Marked 
Neg. to mod. 
Neg. to mod. 
Marked 
Marked 
* All guinea pigs sensitized with  150 #g N anti-HGG and after 18 hours injected with 
soluble complexes  and challenged with 1.0 mg N HGG, except where noted. 
:~ Chlorphenamine injected 10 minutes prior to complexes and antigen. 
§ Pyrilamine injected 30 minutes prior to complexes  and antigen. 
I1 Lysergic acid diethylamide injected 30 minutes prior to complexes  and antigen. 
¶ Guinea pigs sensitized with 0.02 mg N anti-HGG and challenged with 1.0 mg N HGG. 
when soluble complexes were injected intravenously simultaneously with the 
carbachol in 10 guinea pigs, only a trace or no localization of the complexes in 
pulmonary vessels occurred. 
The results,  then,  strongly suggest that upon antigenic  challenge of a  sen- 
sitized guinea pig, in which soluble complexes were present in the circulation, 
that histamine was released in the tissues bringing about at least two events: 
(a)  constriction  of  bronchial  smooth  muscle  with  subsequent  anaphylactic 
death, and (b) alterations in the walls of small vessels leading to deposition of 
the circulating complexes. 
Source of kistamine responsible for the localization:  With the abundant litera- 
ture  pointing  to  the  mast cell  as  a  source  of vasoactive amines,  correlative 
studies were undertaken to find if a relationship existed between the position of CHARLES  O. COCIIRANE  507 
vessels in which complexes  would localize  and  the location of concentrations 
of mast cells in normal guinea pigs. The results showed that affected vessels at 
all times lay in positions where mast cells were grouped, namely in the connec- 
tive tissue septa and  about large vessels  and  structures  that  course through 
organs.  Counts of mast cells in various organs revealed that within a radius of 
0.17 mm of these structures  there were up to  12 times as many mast cells as 
there were outside this zone.  J 
Effect of mast cell disrupting ager~ ~  the localization of circulating complexes: 
Attempts were carried out to see~!~ect attack oa the mast cells by agents 
known to cause release  of hista~~,  these cells would, bring about locali- 
zation  of the  complexes.  Two agents*'w~  used, octylamine and  compound 
"48/80." Intravenous injections of 1 to 50 rng,~of octylamine ha 19 guinea pigs 
brought about few symptoms of anaphylaxis  in tow dosages,  but occasional 
symptoms and fatal collapse in higher  dosage.  Five out d~l 1 gniaea p~.an- 
1  "  "  "  ~  '  "~  alyzed were noted to have had complexes  ocalized in their pulmonary~se~, ~:Z~ 
Only  occasional  vessels  were  revolved in  most  instances,  but  they  show~  '~ 
marked deposition as if maximally affected. Compound 48/80 was found to be 
ineffective in producing localization  in dosages from 0.25 to 1.0 mg when given 
intravenously, even though guinea pigs collapsed and died at the larger dosage 
levels. 
The role of platelets as a source of histamine  in the deposition of circulating 
complexes: Attempts were made to find if circulating platelets, known to con- 
tain histamine and to release it upon contact with antigen-antibody complexes 
(9,  10),  could be the reservoir of histamine  responsible  for the deposition of 
complexes.  Accordingly,  passively  sensitized  guinea  pigs  were  depleted  of 
platelets  by injections  of purified  rabbit  serum  directed  against  guinea  pig 
platelets and then challenged  with soluble complexes and antigen. The results 
of both  anaphylactic  symptoms and  localization  of complexes  are  given  in 
Table III. It may be seen that despite drastic or total elimination of platelets 
from  the  circulation,  fatal  anaphylaxis  occurred  uniformly  upon  antigenic 
challenge,  and  soluble complexes  became localized  equally as well as in un- 
treated control guinea pigs. Sequestered platelets probably did not account for 
these findings,  as fluorescent antibody techniques  failed to demonstrate  the 
presence of platelets in  the pulmonary tissues of guinea  pigs  treated  in  the 
manner outlined. 
3. Anapkylatoxin Shock.--Anaphylatoxin  was prepared as noted above and 
injected into  guinea  pigs  following  the administration  of soluble BSA-anti- 
BSA complexes.  As noted in Table IV, rat anaphylatoxin was capable of pro- 
yoking  localization  of  circulating  complexes  and  systemic shock  typical  of 
antigen-antibody  anaphylaxis.  In  addition,  the  appearance  by fluorescence 
microscopy of the complexes  was identical with that in systemic anaphylaxis, 
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nal  tract,  and  renal  pelvis  was  identical.  Glomerular  capillaries  were  unin- 
volved. Controls, in which preheated rat serum was used instead of fresh serum 
for exposure to immune precipitates showed mild anaphylactic symptoms in 
one out of four cases and an occasional pulmonary vessel with localized com- 
plexes in three out of four cases (all other organs tested failed to demonstrate 
positive vessels). Such activity might result from the formation of aggregated 
gamma globulin  during  heating  either  by direct  action  in  the  guinea  pig  or 
possibly by formation of some anaphylatoxin or other permeability factor during 
the heating process. 
In an attempt to find if anaphylatoxin acted directly on the blood vessels or 
TABLE  III 
Effect of Platdet Depletion on Localization of Circulating Antigen-Antibody  Complexes* 
No. of 
guinea pigs  Platelet count:~ 
t?$~  3 
0 to 4100§ 
203,000 to 383,000 
Complexes 
(N anti-BSA) 
mg 
0.75 
0.75 
Anaphylactic  Vascular  localization 
signs  .  of__complexes 
Death  Marked 
Death  [  Marked 
* All animals sensitized with either t50#g N anti-Ea or anti-HGG and simultaneously 
with  rabbit antiplatelet  antibody.  Eighteen hours later guinea  pigs were injected with a 
small quantity of antiplatelet antibody (see Materials and Methods) and after ~  hour with 
complexes and 1.0 mg N Ea or HGG. 
:~ Performed just prior to injection of complexes and challenging antigen. 
§ Three of the 7 were entirely depleted of circulating platelets. 
da mediators,  the antihistaminic  chlorphenamine was employed. As is noted 
in  Table IV,  chlorphenamine  was  found  capable of completely or markedly 
modifying both systemic shock and localization  of the circulating  complexes 
following provocation by anaphylatoxin. 
4. Forssman Antibody Shock.--Since  the deposition of circulating complexes 
in the walls of vessels appeared to be occurring secondarily to some vascular 
injury or altered physiologic state, an attempt was made to see if direct insult to 
vascular tissue would result in localization.  The agent chosen to produce the 
vascular injury was Forssman antibody, since Forssman antigen is common to 
vascular intima in  guinea pigs  (2).  Accordingly,  8  guinea pigs were injected 
intravenously with soluble BSA-anti-BSA  complexes followed within  15  sec- 
onds by 1.0  to 2.0 ml anti-Forssman antibody. After approximately 15  to 20 
seconds gasping motions and occasional nose rubbing were noted.  The guinea 
pigs staggered and fell in about  1 minute  and death ensued.  Strong signs  of 
histamine  shock such  as lion-maned fur,  sneezing  and  coughing,  and  strong 
inhalatory efforts were absent. Pulmonary distension was present at autopsy, 
however, much like that in anaphylaxis, but considerable amounts  of parch- CHARLES  G.  COCHRANE  509 
chymal hemorrhages were present in addition.  Microscopically, much edema 
and  hemorrhage  was  observable  in  the  alveolar  spaces  and  about  arteries 
although it was difficult to detect any convincing vascular damage. Using the 
fluorescent antibody technique, the complexes were found in the walls of oc- 
casional  venules  of the  lung,  heart,  pancreas,  and  renal  pelvis.  Complexes 
could also be found extensively along the walls of alveolar capillaries as seen 
under high magnification. 
In order to find whether the localization was caused by damage after antibody 
TABLE IV 
The Ability of Ra~ Anaphylatoxin  and Forssman Antibody  to Provoke the Localization of 
CirculaHng Soluble  Antigen-Anlibody  Complexes  in  Guinea Pigs 
No. of 
guinea 
pigs 
4 
7 
4 
211 
Anaphyl- 
atoxin* 
~J 
2.0 
2.0 
2.0§ 
Rabbit 
, Forssman 
antibody 
ml 
1.0 
1.0 
Soluble 
complexes 
(Nanti- 
BSA) 
mg 
0.50 
0.50 
0.50 
0.50 
0.50 
0.50 
* Prepared by exposing washed 
and Methods. 
Antihista- 
minic 
(chlorphen- 
amlne)~ 
mg 
1.0 
1.0 
Systemic shock 
Neg.  Mild  Sev.  Fatal 
7 
4  2 
3  1 
2  5 
4 
2 
immune  precapitates 
Vascular 
localization 
of complexes 
Marked 
Neg. to trace 
Neg. to mild 
Mod. 
Mod. 
Marked 
to  fresh  rat  serum,  see  Materials 
:~ Chlorphenamine injected  intravenously immediately before soluble complexes and 
challenging agent. 
§ Prepared as was anaphylatoxin, but from rat serum heated to 56°C, 15 minutes. 
11 Control guinea pigs, passively sensitized with  150 #g N anti-Ea  and after  18 hours 
injected intravenously with soluble complexes  and challenged  with 1.0 mg N Ea. 
became bound to its antigen in the small vessels or whether again histamine 
played a role as mediator, 8 guinea pigs were given the antihistaminics chlor- 
phenamine  (2  mg intravenously) and pyrilamine  (1  mg intravenously) prior 
to injections of complexes and rabbit anti-Forssman serum. Despite the anti- 
histaminic,  shock  ensued  upon  challenge  and  antigen-antibody  complexes 
localized as before. This was in marked contrast to the inhibitory effects of 
antihistaminics  on  the  localization  of  complexes  occurring  during  antigen- 
antibody or anaphylatoxin anaphylaxis. 
DISCUSSION 
These studies indicate that  during  systemic anaphylactic shock in guinea 
pigs caused by antigen and antibody there occurs an alteration in small vessel 
walls allowing circulating antigen-antibody complexes to localize. The state of 510  CIRCULATING  ANTIGEN-ANTIBODY  COMPLEXES.  II 
shock could be brought about by passive sensitization followed by challenge or 
by a single injection of a large dose of antigen-antibody complexes. The phar- 
macologic agent responsible for the alteration in the vessel walls was found to 
be  histamine,  the  same  agent responsible for the state  of shock.  Clearly 5- 
hydroxytryptamine and choline derivative did not bring about localization of 
circulating complexes in the guinea pigs.  The source of the histamine in these 
studies was not unequivocally determined, although it may have been mast 
cells. By correlative studies mast cells were found to lie in close proximity to the 
affected vessels, and at least in some of the guinea pigs, the mast cell disrupting 
agent octylamine brought about localization. However, the correlation between 
site of mast cell concentration and affected vessels may be coincidental since it 
was found that exogenous histamine caused a similar pattem of involvement. 
This leaves open the possibility that histamine released in a single area of the 
body  into  the  vascular  stream  could  bring  about  permeability changes  in 
vessels and deposition of complexes in distant organs. Platelets could be ruled 
out as a  major source of histamine for both the deposition of complexes and 
anaphylaxis in the guinea pigs, thus confirming and extending the observations 
of Humphrey and Jaques (9). The finding that histamine may cause localiza- 
tion of circulating soluble complexes extends the earlier findings of Benacerraf, 
McCluskey, and Patras (10), who reported that injections of vasoactive amines 
or  soluble complexes into mice brought  about  the  deposition of circulating 
carbon particles in vessels  and heart. They suggested that such reservoirs of 
vasoactive amines as mast cells  could play an important role in the carbon 
localization. 
The effect of the histamine on the vessel walls was probably one of increased 
permeability as determined by the ultrastructural studies reported in the ac- 
companying article,  and  from  the  well  known  observations  that  histamine 
acts  powerfully to  increase vascular permeability.  In  relationship to known 
disease  states,  either human  or  experimental, it  would  seem  possible,  from 
morphologic observations, that the filtration of plasma by vessels normally or 
in a  state of increased permeability could bring about localization of macro- 
molecules. This would be true in such areas as the glomerulus and the endo- 
cardium in experimental serum sickness, where early deposits are clearly found 
between endothelium and basement membrane  (11,  12),  and perhaps  in the 
necrotizing arteritis  of serum  sickness where similar deposits  are  frequently 
seen (13).  Further work will be required, however, to determine whether such 
possibilities  based  on  morphologic  observations  are  justified  by  functional 
evidence. 
Since, in experimental serum sickness in rabbits or in human diseases, severe 
generalized shock does not occur while complexes circulate, as it does in the 
guinea  pigs,  the  localization of  circulating complexes does not  occur  under CHARLES  G. COC~I~ANE  511 
such extreme circumstances.  However, it is certainly within the realm of possi- 
bility that  release  of vasoactive agents  at  a  local  level could occur from  a 
reservoir either fixed at that site, e.g. a mast cell, or from a circulating reservoir, 
e.g. platelets,  and bring about a  local  "shock" condition. With the resulting 
changes in the vessel walls,  localization  of circulating  complexes  could then 
result at that focus.  In this regard, it is of interest that rabbit platelets have 
been shown to be agglutinated by complexes (14) which would allow sequestra- 
tion to. occur, and that rabbit platelets in the presence of antigen and antibody 
and fresh serum release vasoactive amines (15). Further studies have suggested 
a role of platelets in certain systemic immunologic diseases, although the mecha- 
nism  of action is not yet clear  (16). 
The present studies on the biologic activity of anaphylatoxin would indicate 
that anaphylatoxin, when injected intravenously, will cause bronchial muscular 
constriction in guinea pigs and an alteration in venules generally,  probably one 
of increased permeability. It is during this latter event that circulating  com- 
plexes  localized.  These studies corroborate the data of Osler,  eta/.,  (4)  who 
demonstrated  that  anaphylatoxin  produced from rat  serum would cause in- 
creased vascular permeability in the area where it was locally injected and would 
bring about constriction of guinea pig ileum.  In the present studies, the per- 
meability and anaphylactic effects of rat anaphylatoxin were found to be medi- 
ated by histamine. This would suggest a llnl~ in the final pathway of the medi- 
ators  in  anaphylatoxin  and  anaphylactic  shock  in  guinea  pigs.  A  similar 
conclusion was drawn by Hahn and Oberdorf (17) and by Rocha e Silva and 
Aronson (18) by the findings that the effect of anaphylatoxin  was blocked by 
antihistamines and that anaphylatoxin was capable of causing a release of his- 
tamine when peffused through guinea pig lung in vitro. Just how antigen and 
antibody or anaphylatoxin bring about the release  of histamine is not known, 
although  from the work of Mota  (5,  19) both appear to disrupt mast cells. 
Whether the effect on mast cells of antigen and antibody may be mediated by 
anaphylatoxin is a subject of controversy. 
The finding  that antibody directed against Forssman antigen of the vessel 
walls  also  brought  about  localization  of  circulating  complexes  was  not  su- 
prising in view of the above findings  regarding  the alteration of blood vessel 
walls.  Vascular  damage  with  consequent  edema  and  hemorrhage  following 
administration  of the  antibody  were  evident.  Very little  Forssman  antigen 
was noted in the glomerulus  and arteries,  as opposed to the observations of 
Tanaka and Leduc (2), and perhaps as a consequence,  little to no localization 
of complexes  was found in these structures.  The pharmacologic mediation of 
the damage by Forssman antibody was not elucidated in the present study al- 
though  the  action  of  histamine  could  be  ruled  out.  Whether  a  parallel 
mechanism bringing  about the localization  of complexes exists in other experi- 512  CIRCULATING  ANTIGEN-ANTIBODY  COMPLEXES.  IX 
mental models or in human disease conditions is not known. This would neces- 
sarily implicate the action of an autoantibody against vascular tissue rather 
than heterologous antibody as employed in the present study. 
Localization of circulating antigen-antibody complexes in vessels of guinea 
pigs by means of anaphylactic shock was found to be mediated by histamine 
that was released at the time of anaphylaxis. The source of the histamine may 
have been the mast cell as noted in studies employing a  direct attack on the 
mast cells by octylamine. Platelets played apparently little to no role in guinea 
pigs in the anaphylactic deposition of circulating complexes. 
Rat anaphylatoxin was found to cause vascular localization and symptoms of 
anaphylaxis identical with  that brought about  by antigen-antibody anaphy- 
laxis. This also was found to be dependent upon the release of histamine. 
Antibody against  Forssman antigen in the vessel walls of the guinea pigs 
also led to deposition of circulating complexes. This was found not to be his- 
tamine dependent. 
The possible  role of local increase in  vascular  permeability in  certain  ex- 
perimental disease states in the localization of circulating complexes is discussed. 
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